Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT07781007
Starting soon Not applicable

Effectiveness of a Board Game Intervention on Cognitive and Functional Outcomes in Older Adults With Schizophrenia

NCT07781007 · tracked via the Priya Life Science Taiwan tracker
Sponsor
Kaohsiung Kai-Suan Psychiatric Hospital
Phase
Not applicable
Started
2026-09-09
Last updated
2026-09-11

Condition(s) studied

Schizophrenia

Investigational drug(s) / intervention(s)

Scaffolding-Based Board Game Intervention

Scaffolding-Based Board Game Intervention: Participants will receive a scaffolding-based board game intervention once weekly for 12 weeks, with each session lasting approximately 60 minutes.

Study summary

This study aims to evaluate the effects of a scaffolding-based board game intervention on cognitive and functional outcomes in older adults with schizophrenia living in psychiatric nursing homes. Participants will be assigned by clusters to either an intervention group or a control group. The intervention group will receive a 12-week board game training program, while the control group will receive usual care. Cognitive and functional outcomes will be assessed before the intervention, immediately after the 12-week intervention, and three months after the intervention. The study will examine whether the board game intervention can improve cognitive and daily functioning in older adults with schizophrenia.

Eligibility

Sex
ALL
Min age
55 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Aged 55 years or older. 2. Diagnosed with schizophrenia by a board-certified psychiatrist. 3. Has completed at least elementary school education. 4. Has basic verbal communication ability and is able to understand and cooperate with study assessments and activities. 5. Has sufficient vision and hearing, as assessed by care staff, to participate in board game instructions and activities. 6. Is willing to participate in the study and provides written informed consent. Exclusion Criteria: 1. Has severe sensory impairment. 2. Has severe visual or hearing impairment that interferes with participation in the study activities. 3. Has experienced an acute exacerbation of psychiatric symptoms within the past 3 months. 4. Is currently receiving other cognitive training or participating in another research study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Daliao Psychiatric Nursing Home, Kaohsiung Municipal Kai-Syuan Psychiatric Hospital Kaohsiung City Taiwan

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07781007 on ClinicalTrials.gov ↗ ← All trials in Taiwan